tiprankstipranks
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics Financial Overview

Black Diamond Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.363; its P/E ratio is ―; Black Diamond Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 1.14M----
Operating Income$ -86.46M$ -92.83M$ -126.87M$ -69.57M$ -29.33M
EBITDA$ -82.00M$ -92.32M$ -126.67M$ -67.20M$ -35.21M
Net Income$ -82.44M$ -91.17M$ -125.60M$ -67.25M$ -35.26M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 158.57M$ 156.25M$ 247.68M$ 329.67M$ 158.29M
Total Debt$ 22.18M$ 25.30M$ 28.14M$ 7.69M$ 0.00
Net Debt$ -109.22M$ -97.51M$ -181.65M$ -307.37M$ -154.67M
Total Liabilities$ 41.83M$ 40.56M$ 51.78M$ 21.91M$ 205.45M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -66.66M$ -85.27M$ -102.86M$ -52.29M$ -24.70M
Operating Cash Flow$ -66.72M$ -85.08M$ -100.15M$ -52.15M$ -24.67M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Black Diamond Therapeutics Debt to Assets

Black Diamond Therapeutics Cash Flow

Black Diamond Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis